Galiximab (Anti-CD28L / CD80)
Product Specifications
CAS Number
357613-77-5
Synonyms
IDEC 114; Anti-Human CD80 Recombinant Antibody
Target
CD markers
Applications
Transmembrane Transporters
Additionnal Information
Galiximab (Anti-CD28L/CD80) is a primatized immunoglobulin G1 (IgG1) lambda monoclonal antibody targeting against the CD80 antigen. Galiximab has variable regions are primatized (cynomologous monkeys), and the constant regions are human. Galiximab can be used in research of B-cell lymphoma. MW:145.5 KD.
Storage Conditions
Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog